Alabama Reaffirms State Control Over Telehealth Prescribing of Controlled Substances

What this means for your practice

For telehealth brands, medspas, dental practices, chiropractic offices, and other healthcare businesses operating or planning to operate in Alabama, this guidance from the ALBME is critical. It reinforces that state-specific laws, not just federal guidelines, dictate the parameters for controlled substance prescribing via telehealth. Practices must ensure their clinicians (physicians, PAs, CRNPs, CNMs) are not only aware of but actively complying with Alabama's unique requirements, including specific CME mandates for obtaining and renewing Controlled Substances Certificates (ACSC/QACSC). Ignoring state-level stricter requirements could lead to significant regulatory violations, investigations, and disciplinary actions. Moreover, the emphasis on understanding the medical board investigative process and documentation practices underscores the need for robust compliance infrastructure.

Montgomery, AL – The Alabama Board of Medical Examiners (ALBME) has underscored a critical regulatory principle: state law ultimately dictates the controlling rules for telehealth prescribing of controlled substances, even in the presence of federal flexibilities. This clarification is particularly pertinent for healthcare professionals and organizations engaged in providing care across state lines or utilizing telehealth modalities within Alabama.

The ALBME highlights that while federal regulations may offer certain allowances for prescribing controlled substances via telehealth, these do not supersede potentially stricter, state-specific requirements. Practitioners operating in Alabama are explicitly required to comply with the state's statutes and administrative rules.

ALBME's Role in Ensuring Compliance

To aid practitioners in navigating this complex regulatory landscape, the ALBME offers a comprehensive Continuing Medical Education (CME) course titled "Prescribing and Pharmacology of Controlled Substances." This course is a foundational element of the Board's strategy to ensure safe, effective, and compliant prescribing practices within the state.

Who Should Attend?

The course is specifically designed for a wide range of healthcare professionals who prescribe controlled medications. This includes:

• Physicians in all specialties
• Physician Assistants (PAs)
• Certified Registered Nurse Practitioners (CRNPs)
• Nurse Midwives (CNMs)

The stated goal is to enhance their knowledge and ability to effectively prescribe controlled medications, particularly those with a high potential for misuse and abuse.

CME Requirements for Controlled Substances Certificates

Adherence to the ALBME's CME requirements is crucial for holders of Controlled Substances Certificates:

• Holders of an Alabama Controlled Substances Certificate (ACSC): Any two hours of the 12-hour prescribing course or other Board-approved course meets the ALBME CME rule requiring holders of an ACSC to have, every two years, 2 AMA PRA Category 1 Credits™ of CME in prescribing controlled substances.
• Holders of a Qualified Alabama Controlled Substances Certificate (QACSC): The full 12-hour prescribing course is mandated for PAs, CRNPs, and CNMs to initially obtain a QACSC. For renewal, these practitioners must attend four hours of the 12-hour prescribing course, or any other Board-approved prescribing controlled substances course, every two years.

Addressing Emerging Gaps in Controlled Substance Prescribing

The ALBME identifies several emerging gaps that necessitate updated education for clinicians. These include:

• Regulatory Compliance and Investigative Process: Many clinicians are unfamiliar with the medical board investigative process, behaviors that commonly prompt complaints, effective documentation practices that support compliance, and appropriate communication with investigators.
• Complex Pharmacology: A clearer understanding of the pharmacology, mechanisms of action, and associated risks of drugs like ketamine (for pain and treatment-resistant depression) is needed. Rising prescribing rates of psychostimulants and benzodiazepines also underscore the need to understand the neurobiological mechanisms of addictive disease.
• Telehealth Prescribing Challenges: Clinicians continue to encounter challenges in safely and legally prescribing controlled substances via telehealth, managing unique populations such as hospice patients, and navigating the QACSC/LPSP application and renewal processes.

Participant Learning Objectives

Through the CME activity, participants are expected to gain critical competencies, including the ability to:

• Describe the pharmacology of various controlled drugs and their implications for prescribing decisions.
• Identify Alabama-specific laws and regulations governing the prescribing of controlled substances via telehealth.
• Distinguish how to safely and legally prescribe controlled substances via telehealth, ensuring proper monitoring and documentation.
• Explain accessing and utilizing the Prescription Drug Monitoring Program (PDMP) as a clinical tool.
• Define the rules and protocols that govern controlled prescribing.
• Describe best practices for prescribing medications like buprenorphine and testosterone.
• Recognize characteristics of substance-seeking patients and prevent diversion.
• Explain the role of BME investigators and the steps of the investigation process.
• Identify prescribing behaviors that lead to complaints or disciplinary actions.

This comprehensive approach by the ALBME underscores Alabama's commitment to maintaining rigorous oversight of controlled substance prescribing, particularly as telehealth continues to expand.

Key Facts

| Detail | Value | |---|---| | Governing Principle | State law dictates the controlling rule for telehealth prescribing of controlled substances, even with federal flexibility. | | ALBME CME Course | Prescribing and Pharmacology of Controlled Substances. | | ACSC CME Requirement | 2 AMA PRA Category 1 Credits™ of CME in prescribing controlled substances every two years. | | QACSC Initial Requirement | Complete the 12-hour prescribing course. | | QACSC Renewal Requirement | Attend four hours of the 12-hour prescribing course, or other Board-approved course, every two years. | | Upcoming Course | November 2026 conference for Prescribing and Pharmacology of Controlled Substances. |

Frequently Asked Questions

Do federal flexibilities for telehealth prescribing override Alabama's state laws for controlled substances?

No, even with federal flexibility, practitioners in Alabama must comply with any stricter state-specific requirements, as state law ultimately dictates the controlling rule for telehealth prescribing of controlled substances.

What is the Alabama Board of Medical Examiners (ALBME) doing to help practitioners comply?

The ALBME offers a comprehensive CME course titled 'Prescribing and Pharmacology of Controlled Substances' designed to increase knowledge and ability to effectively prescribe controlled medications compliantly.

Who is required to take the ALBME's controlled substances prescribing course?

Physicians in all specialties, Physician Assistants (PAs), Certified Registered Nurse Practitioners (CRNPs), and Nurse Midwives (CNMs) who need to increase their knowledge. Specifically, the 12-hour course is required for PAs, CRNPs, and CNMs to obtain a Qualified Alabama Controlled Substances Certificate (QACSC).

What are the CME requirements for renewing a QACSC in Alabama?

To renew a QACSC, PAs, CRNPs, and CNMs must attend four hours of the 12-hour prescribing course, or any other Board-approved prescribing controlled substances course, every two years.

Does the course address specific challenges related to telehealth prescribing?

Yes, one of the participant learning objectives is to identify Alabama-specific laws and regulations governing the prescribing of controlled substances via telehealth and to distinguish how to safely and legally prescribe controlled substances via telehealth, ensuring proper monitoring and documentation.

Source: albme.gov — State Laws Maintain Control Over Telehealth Controlled Substance Prescribing